Dyne Therapeutics
83 hedge funds and large institutions have $573M invested in Dyne Therapeutics in 2021 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 24 increasing their positions, 21 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
1.15% less ownership
Funds ownership: 69.92% → 68.77% (-1.1%)
24% less capital invested
Capital invested by funds: $753M → $573M (-$180M)
Holders
83
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$25.4M | |
| 2 | +$2.37M | |
| 3 | +$2.28M | |
| 4 |
Norges Bank
Oslo,
Norway
|
+$1.9M |
| 5 |
IBT
International Biotechnology Trust
London,
United Kingdom
|
+$1.87M |
Top Sellers
| 1 | -$24.6M | |
| 2 | -$16.6M | |
| 3 | -$7.36M | |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
-$4.1M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
-$2.64M |